Download our complimentary white paper on the HRSA 340B Drug Pricing Program Patient Definition, Provider Eligibility and Referral Prescriptions

A Primer for 340B Professionals

Screen Shot 2017-06-14 at 2.59.31 PM.png


This white paper provides an overview of the U.S. Department of Health and Human Services (HHS) Health Resources and Services Administration's (HRSA) 340B Drug Discount Pricing Program with a particular focus on aspects of legislation and regulation that impact patient definition and referral prescriptions.

In addition to a brief overview of the program's origin and history, this paper further provides an in-depth analysis of patient definition by describing:

  • HHS and Apexus positions with respect to patient and provider eligibility.
  • Current and historical guidelines on patient definition with an emphasis on referral prescriptions.
  • An exclusive data analysis from eight 340B CE contract pharmacies and vendor partners revealing overall referral prescription capture rate at 2% and specialty capture nearly absent.
  • Operational and technical challenges involved in capturing referral prescriptions in a manner that satisfies HRSA audits.
  • How par8o 340B Referral Capture solves current challenges.